{"id":57793,"date":"2024-02-27T18:00:17","date_gmt":"2024-02-27T18:00:17","guid":{"rendered":"https:\/\/medsname.com\/ivabrad\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"ivabrad","status":"publish","type":"product","link":"https:\/\/medsbase.com\/sv\/product\/ivabrad\/","title":{"rendered":"Ivabrad"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Ivabrad?<\/h3>\n<p style=\"margin:0;\"><strong>Ivabrad<\/strong> is 7.5 mg ivabradine tablets from a WHO-GMP certified manufacturer &mdash; a selective inhibitor of the <strong>I<sub>f<\/sub> (&#8220;funny&#8221;) current<\/strong> in the sinoatrial node. Ivabradine was introduced by Servier in 2005 as <strong>Procoralan<\/strong> &mdash; the first drug to selectively slow heart rate without affecting blood pressure, myocardial contractility, or other ion channels. Targets the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that generate the I<sub>f<\/sub> current responsible for spontaneous SA node depolarisation. selectively blocks I<sub>f<\/sub> in the sinoatrial node, reducing the slope of spontaneous diastolic depolarisation and slowing heart rate. Unlike beta-blockers and non-DHP CCBs, ivabradine has no effect on cardiac contractility, BP, or AV node conduction &mdash; it is a &#8220;pure&#8221; bradycardia agent. Dosing: Start 5 mg twice daily with food; titrate to 7.5 mg twice daily at 2 weeks if resting HR &gt;60 bpm and tolerated. Reduce to 2.5 mg twice daily if HR falls below 50 bpm or symptoms develop. In elderly (&gt;75 yr) start 2.5 mg twice daily. Arrhythmia management is a cardiology-led discipline &mdash; diagnosis, drug selection, and monitoring typically require specialist input. This is not a drug for self-initiated therapy.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Vad du f\u00e5r med MedsBase:<\/strong> WHO-GMP-certifierad tillverkare \u00b7 Diskret f\u00f6rpackning \u00b7 V\u00e4rldsvid leverans \u00b7 1 400+ verifierade <a href=\"https:\/\/medsbase.com\/sv\/reviews\/\">kundrecensioner<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r <a href=\"https:\/\/medsbase.com\/sv\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n<h3>Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n<p>V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rldsvidt i diskreta, enkla f\u00f6rpackningar \u2014 inget l\u00e4kemedelsnamn p\u00e5 f\u00f6rs\u00e4ndelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Ivabrad?<\/h2>\n<p>Ivabrad is 7.5 mg ivabradine tablets from a WHO-GMP certified manufacturer, supplied in 30-180 tablets. Ivabradine was introduced by Servier in 2005 as <strong>Procoralan<\/strong> &mdash; the first drug to selectively slow heart rate without affecting blood pressure, myocardial contractility, or other ion channels. Targets the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that generate the I<sub>f<\/sub> current responsible for spontaneous SA node depolarisation.<\/p>\n<h2 class=\"wp-block-heading\">How Ivabradine Works<\/h2>\n<p>Ivabradine selectively blocks I<sub>f<\/sub> in the sinoatrial node, reducing the slope of spontaneous diastolic depolarisation and slowing heart rate. Unlike beta-blockers and non-DHP CCBs, ivabradine has no effect on cardiac contractility, BP, or AV node conduction &mdash; it is a &#8220;pure&#8221; bradycardia agent.<\/p>\n<h2 class=\"wp-block-heading\">Godk\u00e4nda Anv\u00e4ndningsomr\u00e5den<\/h2>\n<ul>\n<li><strong>Chronic symptomatic heart failure with reduced ejection fraction (HF-REF)<\/strong> &mdash; in patients with EF &le;35%, sinus rhythm, and heart rate &gt;70 bpm despite maximum-tolerated beta-blocker (or beta-blocker intolerance). <strong>SHIFT trial evidence.<\/strong><\/li>\n<li><strong>Kronisk stabil angina<\/strong> &mdash; add-on to beta-blocker or alone where beta-blockers are contraindicated. <strong>BEAUTIFUL and SIGNIFY trials.<\/strong><\/li>\n<li>Inappropriate sinus tachycardia (off-label)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Dosering och uppf\u00f6ljning<\/h2>\n<p><strong>Dosering:<\/strong> Start 5 mg twice daily with food; titrate to 7.5 mg twice daily at 2 weeks if resting HR &gt;60 bpm and tolerated. Reduce to 2.5 mg twice daily if HR falls below 50 bpm or symptoms develop. In elderly (&gt;75 yr) start 2.5 mg twice daily.<\/p>\n<p><strong>\u00d6vervakning:<\/strong><\/p>\n<ul>\n<li><strong>Baslinje:<\/strong> 12-lead ECG (confirm sinus rhythm, assess HR and QT), BP, U&amp;E.<\/li>\n<li><strong>2-4 weeks:<\/strong> HR review; titrate up or down.<\/li>\n<li><strong>P\u00e5g\u00e5ende:<\/strong> periodic HR and ECG; target resting HR 50-60 bpm in HF-REF.<\/li>\n<li><strong>Avbryt vid:<\/strong> symptomatic bradycardia (HR &lt;50 with symptoms), new AF (ivabradine efficacy is sinus-rhythm dependent), visual phenomena severe enough to affect driving\/work.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Biverkningar<\/h2>\n<ul>\n<li><strong>Luminous phenomena (phosphenes)<\/strong> &mdash; transient enhanced brightness in peripheral vision (15%); usually improves spontaneously. Mechanism: ivabradine also weakly blocks I<sub>h<\/sub> current in retinal photoreceptors.<\/li>\n<li><strong>Bradykardi<\/strong> &mdash; dose-limiting (5-10%)<\/li>\n<li><strong>F\u00f6rmaksflimmer<\/strong> &mdash; modest excess vs placebo in trials; the drug is not effective once sinus rhythm is lost<\/li>\n<li><strong>Huvudv\u00e4rk, yrsel<\/strong><\/li>\n<li><strong>First-degree AV block, ventricular extrasystoles<\/strong><\/li>\n<li><strong>Utslag<\/strong><\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikationer<\/h2>\n<ul>\n<li>Resting HR &lt;70 bpm before starting<\/li>\n<li>Cardiogenic shock, acute MI<\/li>\n<li>Sv\u00e5r hypotoni<\/li>\n<li>Sick sinus syndrome, sinoatrial block, third-degree AV block without pacemaker<\/li>\n<li>Unstable or acute heart failure<\/li>\n<li>Atrial fibrillation (not effective; may worsen rate control)<\/li>\n<li>Pacemaker-dependent<\/li>\n<li>Sv\u00e5r leversvikt<\/li>\n<li>Strong CYP3A4 inhibitor co-therapy<\/li>\n<li>Graviditet och amning<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">L\u00e4kemedelsinteraktioner<\/h2>\n<ul>\n<li><strong>Starka CYP3A4-h\u00e4mmare \u2014 KRITISKT.<\/strong> Contraindicated: clarithromycin, itraconazole, ketoconazole, ritonavir, nefazodone, nelfinavir. Caution with moderate inhibitors (diltiazem, verapamil \u2014 note these also add bradycardia independently).<\/li>\n<li><strong>Diltiazem, verapamil<\/strong> &mdash; avoid (additive bradycardia + CYP3A4 inhibition).<\/li>\n<li><strong>QT-f\u00f6rl\u00e4ngande l\u00e4kemedel<\/strong> &mdash; caution; ivabradine has minimal intrinsic QT effect but combined risk rises.<\/li>\n<li><strong>Grapefruktjuice<\/strong> &mdash; raises ivabradine levels.<\/li>\n<li><strong>Betablockare<\/strong> &mdash; combination is standard in HF-REF where beta-blocker alone is inadequate; watch for additive bradycardia.<\/li>\n<\/ul>\n<h2 id=\"faqs\">Vanliga fr\u00e5gor<\/h2>\n<h3 class=\"wp-block-heading\">What are the visual phosphenes?<\/h3>\n<p>About 15% of patients experience transient enhanced brightness in peripheral vision &mdash; particularly when looking from dim to bright light. They are benign (ivabradine weakly blocks a similar current in retinal photoreceptors) and usually adapt over weeks. Severe phenomena that affect driving or work are indication to stop.<\/p>\n<h3 class=\"wp-block-heading\">Can I take ivabradine if I have atrial fibrillation?<\/h3>\n<p>No &mdash; ivabradine only slows the sinoatrial node, so it has no effect on AF and may even make rate control worse. In AF use beta-blockers, non-DHP CCBs, or digoxin instead.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Ivabrad in pregnancy?<\/h3>\n<p>Generally no. Ivabradine has animal teratogenicity data; pregnancy is contraindicated in the licensed indications.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Ivabrad online?<\/h3>\n<p>You can buy Ivabrad (ivabradine 7.5 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n<h2 class=\"wp-block-heading\">Relaterade kardiovaskul\u00e4ra l\u00e4kemedel<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/abana\/\">Abana \u2014 Ayurvedisk hj\u00e4rtformulering<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/aldactone\/\">Aldactone \u2014 Spironolakton<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/cardace\/\">Cardace \u2014 Ramipril (ACE-h\u00e4mmare)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/ecosprin\/\">Ecosprin \u2014 Aspirin 75\/150 mg (antiplatelet)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/lonitab\/\">Lonitab \u2014 Minoxidil 5 mg (oralt vaskul\u00e4rt dilaterande medel)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/vymada\/\">Vymada \u2014 Sacubitril\/Valsartan ARNI<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/high-blood-pressure-medication\/\"><strong>Bl\u00e4ddra bland alla blodtryckss\u00e4nkande l\u00e4kemedel<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Medicinsk ansvarsfriskrivning.<\/strong> Denna sida \u00e4r endast avsedd f\u00f6r informations\u00e4ndam\u00e5l och ers\u00e4tter inte medicinsk r\u00e5dgivning fr\u00e5n en kvalificerad v\u00e5rdgivare. Hypertoni, hj\u00e4rtsvikt och arytmier kr\u00e4ver diagnos, uppf\u00f6ljning och dosindividualisering av en l\u00e4kare \u2014 anv\u00e4nd alltid betablockerare under medicinsk \u00f6vervakning.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterade alternativ<\/h3>\n<p>Andra produkter inom <strong>Kroniska tillst\u00e5nd<\/strong> som kunder \u00e4ven tittar p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/prilox-cream\/\">Prilox Cream<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/rozucor\/\">Rozucor<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/lasix\/\">Lasix<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/meftal\/\">Meftal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/carvego\/\">Carvego<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Ivabrad is ivabradine 7.5 mg tablets \u2014 the first selective I-f current inhibitor, acting at the sinoatrial node to slow heart rate without affecting blood pressure, contractility, or AV conduction. Originally Servier Procoralan (2005). SHIFT trial validated in HF-REF with HR >70 despite beta-blocker; BEAUTIFUL\/SIGNIFY extended evidence to chronic stable angina. Only effective in sinus rhythm \u2014 not for atrial fibrillation. Contraindicated with strong CYP3A4 inhibitors.<\/p>","protected":false},"featured_media":57794,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[4359,4360],"class_list":{"0":"post-57793","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-ivabrad","11":"product_tag-ivabradine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/57793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=57793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/57794"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=57793"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=57793"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=57793"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=57793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}